Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Evaluation of cell function upon nanovector internalization.

Martinez JO, Parodi A, Liu X, Kolonin MG, Ferrari M, Tasciotti E.

Small. 2013 May 27;9(9-10):1696-702. doi: 10.1002/smll.201202001. Epub 2012 Nov 20.

2.

Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery.

Veiseh O, Kievit FM, Mok H, Ayesh J, Clark C, Fang C, Leung M, Arami H, Park JO, Zhang M.

Biomaterials. 2011 Aug;32(24):5717-25. doi: 10.1016/j.biomaterials.2011.04.039. Epub 2011 May 13.

3.

Alkyl-capped silicon nanocrystals lack cytotoxicity and have enhanced intracellular accumulation in malignant cells via cholesterol-dependent endocytosis.

Alsharif NH, Berger CE, Varanasi SS, Chao Y, Horrocks BR, Datta HK.

Small. 2009 Feb;5(2):221-8. doi: 10.1002/smll.200800903.

4.

Increasing cellular uptake of mesoporous silica nanoparticles in human embryonic kidney cell line 293T cells by using Lipofectamine 2000.

Wang J, Teng Z, Tian Y, Fang T, Ma J, Sun J, Zhu F, Wu J, Wang X, Yang N, Zhou X, Yun S, Lu G.

J Biomed Nanotechnol. 2013 Nov;9(11):1882-90.

PMID:
24059087
5.

Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.

Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Brown BS, Liu X, Ferrari M, Tasciotti E.

Small. 2013 May 27;9(9-10):1722-33. doi: 10.1002/smll.201201939. Epub 2012 Dec 16.

6.

Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking.

Huang DM, Hung Y, Ko BS, Hsu SC, Chen WH, Chien CL, Tsai CP, Kuo CT, Kang JC, Yang CS, Mou CY, Chen YC.

FASEB J. 2005 Dec;19(14):2014-6. Epub 2005 Oct 17.

PMID:
16230334
7.

Biocompatibility, uptake and endocytosis pathways of polystyrene nanoparticles in primary human renal epithelial cells.

Monti DM, Guarnieri D, Napolitano G, Piccoli R, Netti P, Fusco S, Arciello A.

J Biotechnol. 2015 Jan 10;193:3-10. doi: 10.1016/j.jbiotec.2014.11.004. Epub 2014 Nov 18.

PMID:
25444875
8.

Design maps for cellular uptake of gene nanovectors by computer simulation.

Ding HM, Ma YQ.

Biomaterials. 2013 Nov;34(33):8401-7. doi: 10.1016/j.biomaterials.2013.06.067. Epub 2013 Jul 26.

PMID:
23891080
9.

Internalization of titanium dioxide nanoparticles by glial cells is given at short times and is mainly mediated by actin reorganization-dependent endocytosis.

Huerta-García E, Márquez-Ramírez SG, Ramos-Godinez Mdel P, López-Saavedra A, Herrera LA, Parra A, Alfaro-Moreno E, Gómez EO, López-Marure R.

Neurotoxicology. 2015 Dec;51:27-37. doi: 10.1016/j.neuro.2015.08.013. Epub 2015 Sep 2.

PMID:
26340880
10.

Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells.

Huang DM, Chung TH, Hung Y, Lu F, Wu SH, Mou CY, Yao M, Chen YC.

Toxicol Appl Pharmacol. 2008 Sep 1;231(2):208-15. doi: 10.1016/j.taap.2008.04.009. Epub 2008 Apr 25.

PMID:
18519141
11.

Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.

Liu Q, Zhang J, Xia W, Gu H.

Nanoscale. 2012 Jun 7;4(11):3415-21. doi: 10.1039/c2nr30352c. Epub 2012 Apr 30.

PMID:
22543531
12.

The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.

Huang X, Teng X, Chen D, Tang F, He J.

Biomaterials. 2010 Jan;31(3):438-48. doi: 10.1016/j.biomaterials.2009.09.060. Epub 2009 Oct 1.

PMID:
19800115
13.

Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.

Gupta AK, Berry C, Gupta M, Curtis A.

IEEE Trans Nanobioscience. 2003 Dec;2(4):255-61.

PMID:
15376916
14.

Cellular uptake and toxicity effects of silver nanoparticles in mammalian kidney cells.

Milić M, Leitinger G, Pavičić I, Zebić Avdičević M, Dobrović S, Goessler W, Vinković Vrček I.

J Appl Toxicol. 2015 Jun;35(6):581-92. doi: 10.1002/jat.3081. Epub 2014 Oct 28.

PMID:
25352480
15.

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ.

Acc Chem Res. 2013 Mar 19;46(3):792-801. doi: 10.1021/ar3000986. Epub 2013 Feb 6.

16.

Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells.

Passagne I, Morille M, Rousset M, Pujalté I, L'azou B.

Toxicology. 2012 Sep 28;299(2-3):112-24. doi: 10.1016/j.tox.2012.05.010. Epub 2012 May 22.

PMID:
22627296
17.

Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.

Contreras-Ruiz L, de la Fuente M, Párraga JE, López-García A, Fernández I, Seijo B, Sánchez A, Calonge M, Diebold Y.

Mol Vis. 2011 Jan 27;17:279-90.

18.

Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.

Niemelä E, Desai D, Nkizinkiko Y, Eriksson JE, Rosenholm JM.

Eur J Pharm Biopharm. 2015 Oct;96:11-21. doi: 10.1016/j.ejpb.2015.07.009. Epub 2015 Jul 14.

PMID:
26184689
19.

Particle size influences fibronectin internalization and degradation by fibroblasts.

Bozavikov P, Rajshankar D, Lee W, McCulloch CA.

Exp Cell Res. 2014 Oct 15;328(1):172-85. doi: 10.1016/j.yexcr.2014.06.018. Epub 2014 Jul 1.

PMID:
24995996
20.

A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

Veiseh O, Kievit FM, Gunn JW, Ratner BD, Zhang M.

Biomaterials. 2009 Feb;30(4):649-57. doi: 10.1016/j.biomaterials.2008.10.003. Epub 2008 Nov 5.

Supplemental Content

Support Center